Post-Market Surveillance: How the FDA Monitors Generic Drugs After Approval
The FDA doesn't stop monitoring generic drugs after approval. Using FAERS, Sentinel, MedWatch, and inspections, it tracks safety in real time. Learn how the system catches hidden risks and protects millions of patients.